Experiments were undertaken to assess the role of amifostine in the activation of latent TGF␤1 and in the smad proteins cascade (smad 2/3, smad4, smad7), focusing on megakaryocytes, in the bone marrow irradiated in vivo. Non-irradiated megakaryocytes were negative for active TGF␤1. Immunopositivity to active TGF␤1 was detected in megakaryocytes 10 days after irradiation in amifostine-treated and untreated marrows. Smad 2/3 and smad 4 were strongly positive in the nucleus of megakaryocytes 10 days after irradiation. At the same time, a predominant hypocellular bone marrow with foci of hematopoiesis was observed with few megakaryocytes. An increase in the number of reticulin fibers was also seen. In amifostine-treated marrows, smad 2/3 and smad4 were not detected in the nucleus but were positive in the cytoplasm of megakaryocytes 10 days after irradiation. Coincidentally, bone marrows were cellular with megakaryocytes. Smad7 immunoexpression was detected in the cytoplasm of megakaryocytes in the non-irradiated, amifostine-treated and in the irradiated, amifostine-treated marrows. Data indicate that amifostine does not prevent latent TGF␤1 activation in irradiated megakaryocytes. While TGF␤1 signal transduction occurs in megakaryocytes in untreated bone marrows, it is inhibited in megakaryocytes in amifostine-treated marrows due to the induction of smad 7 activation. This is the first report showing smad 7 activation by amifostine. Our results also suggest a role for TGF␤1 as an inhibitor of megakaryocytes in vivo. Am. J. Hematol. 71:143-151, 2002.
INTRODUCTION
The bone marrow, following irradiation, is an acute responding tissue. It can be severely injured after accidental exposures to radiation and also constitutes a critical organ in the interaction between drugs and radiation during the treatment of malignant neoplasias, sometimes limiting such treatment [1, 2] . Depending on the volume of irradiated bone marrow and the radiation dose, a pancytopenia, primarily leucopenia and thrombocytopenia, can occur in the peripheral blood due to the injury to stem cells [1, 2] , resulting in infection, bleeding, and anemia caused by hemorrhage [3] . Myelofibrosis can also develop as a late effect of radiation [4] . Therefore, protection of the bone marrow cells is highly desired in clinical situations.
Amifostine, S-2-(3-aminopropylamino)ethylphosphorothioic acid, is an aminothiol phosphorothioate which contains phosphate moieties covering the sulfhydryl group in order to prevent the oxidation seen with free thiol groups. It cannot be transported across the cell membrane until the phosphate group is cleaved. This is accomplished enzymatically by alkaline phosphatase, which is membrane bound in many cells, particularly in normal tissues. Amifostine has been found to protect preferentially normal tissues, as opposed to tumors against radiation injuries [6] , and bone marrow is one of the most protected organs [7] [8] [9] . In the gastrointestinal tract, amifostine has been found to protect from radiation-induced fibrosis [10] .
There are several hypotheses for the mechanisms by which amifostine protects against radiation and chemotherapy toxicities, these include oxygen depletion [6, 11] , hydrogen atom donation [11] , enhancement of cell cycle arrest [12] , and scavenging of free radicals [13] . However, these mechanisms have not yet been clearly established.
In physiological conditions, hematopoietic stem cells undergo self-replication, proliferation, and differentiation into mature blood cells. All these processes are regulated by stimulatory and inhibitory hematopoietic growth factors [14] .
Transforming growth factor ␤ (TGF␤) is a multifunctional regulator of cell proliferation and differentiation, and it has been found to be one of the cytokines involved in the regulation of hematopoiesis [15, 16] . Present in mammals as three distinct isoforms, TGF␤1, TGF␤2, and TGF␤3 [17] , the TGF␤ proteins are synthesized as inactive protein precursors with the latency associated peptide (LAP) [18] . The activation occurs after heat or acid treatment [19] , plasmin proteolysis [20] , deglycosylation [21] , binding to thrombospondin [22] , or oxidative stress [23] , when TGF␤ is released from LAP. In general, mammals possess receptors to TGF␤s and the peptide regulates cell function via paracrine and autocrine systems [17] .
A group of structurally related proteins, referred to as smads, has been shown to transduce signals downstream from TGF␤ family receptors. The first member of the smad family was identified in a genetic screen for modifiers of decapentaplegic (dpp), the ortholog fly of bone morphogenic protein 2/4 (a member of TGF␤ family), in Drosophila. This smad was originally named Mothers against dpp (Mad) and encodes a protein that transduces signals downstream of dpp. The vertebrate ortholog of Mad, smad 1, as well as a number of other smads that function downstream from distinct TGF␤ family members, have since been identified [24, 25] . When TGF␤ is released from LAP, it binds to type II serine/threonine kinase receptor (T␤RII) which phosphorylates T␤RI. After activation by T␤RI, smad 2 and smad3 transiently interact with and become phosphorylated [26] . They then oligomerize with the common mediator, smad 4 [27] . The hetero-oligomeric complex is then translocated to the nucleus and regulates the transcription of target genes [28] . The inhibitory smads, smad6 and smad7, form a stable interaction with the activated receptor type I (T␤RI) and prevent binding to and activation of smad2 and smad3 [29] . Smad 7, in particular, was found to be predominantly localized in the nucleus and accumulates in the cytoplasm following TGF␤ receptor activation [30] .
In the bone marrow, TGF␤ was found to inhibit the proliferation and differentiation of murine and human early hematopoietic progenitors, in vitro, and appears to stimulate the growth of less primitive progenitors [7, 31] . It regulates the growth of human marrow fibroblasts as well as collagen and fibronectin synthesis [32] .
TGF␤ was detected immunohistochemically in megakaryocytes and some mononuclear cells [33] . Peripheral blood monocytes and neutrophils have been found to produce TGF␤1 [34] ; however, megakaryocytes are a major site of synthesis and storage of TGF␤ [35] . It has been shown that mature megakaryocytes synthesize TGF␤1 and package it intracellularly into ␣-granules [35] . In platelets, TGF␤ was found stored in the latent form [35, 36] .
TGF␤ has been shown to be a potent inhibitor of megakaryocytes in vitro [37, 38] , but its role in megakaryocytic homeostasis has not yet been established in vivo [35] . TGF␤ was also found increased in some hematological diseases, such as myelofibrosis [39] , and megakaryocytes are suggested to be one of the possible sources of the proteins [40, 41] . For these reasons we focused on megakaryocytes in the present study.
It has been shown that radiation activates latent TGF␤ and radiation-induced fibrosis [42, 43] . Induction of TGF␤ was detected in 1 hr and also 3 and 7 days after irradiation in mammary gland cells. This increase was related to collagen III remodeling [42, 44] . Induction of TGF␤ protein and mRNA were detected in skin 6 hr after irradiation [43] . In the bone marrow, in vivo, no significant increase in TGF␤ mRNA was detected after irradiation [45] . However, regulation at the TGF␤ protein activation level could occur without regulation at the level of transcription or translation [43] . It is suggested that the rapid latent TGF␤ activation after irradiation is due to radiation generated reactive oxygen [23, 44] . The continued elevation is suggested to be cell-mediated, possibly via plasmin [23, 44] .
Experiments have shown that latent TGF␤ proteins are redox sensitive [23, 44] . TGF␤1 induces the release of hydrogen peroxide (H 2 O 2 ) from human lung fibroblasts [46] . The expression of antioxidative enzymes such as manganese-superoxide dismutase, copper, zincsuperoxide dismutase, and catalase were suppressed by TGF␤1 in hepatocytes of rats [47] . The overall intracellular oxidized state of mouse osteoblastic cell line was increased after addition of TGF␤, and this increase was abolished by the addition of radical scavengers such as catalase and n-acetylcysteine [48] . Thiol modulation of TGF␤1 antiproliferative effects in endothelial cells has also been reported [49] . When cysteine, cysteamine, and n-acetylcysteine were added to endothelial cell cultures, TGF␤1 inhibition of radioactive thymidine (TdR) uptake and also the inhibition of cell proliferation were attenuated [49] .
In the present study, we used immunohistochemistry to assess the role of amifostine in the activation of latent TGF␤1 and in the smad proteins cascade (smad 2/3, smad 4, and smad 7), focusing on megakaryocytes, in the bone marrow irradiated in vivo.
METHODS AND MATERIALS

Animals
Eighty-four (84) adult male C57Bl mice (20-24 g) were used. The study was approved by the Federal University of São Paulo Board for Laboratory Animals.
During experiments, the mice were kept in plastic cages on sawdust, with chow and tap water available ad libitum. Animals were randomly assigned to the following groups. Twenty-four mice received 0.5 mL of an aqueous solution of 400 mg/kg amifostine i.p., 30 min prior to irradiation and were assigned into subgroups and sacrificed at the same intervals as in group 3.
Radiation Factors
A 60
Co irradiation source (Teletherapy machineAlcyon II, CGR) with a dose rate of 1.35 Gy min −1 was used. The mice received a single whole-body radiation dose of 7 Gy. During irradiation, the animals were placed in a special 20 × 20 wooden box with a plastic cover and internal divisions for immobilization, without anesthesia.
Bone Marrow
The left femora were removed, fixed in formol + base 5, decalcified, and embedded in Historesin, for morphology and histometry. The right femora were fixed in phosphate-buffered formalin and after decalcification were embedded in synthetic paraffin for immunohistochemistry. Sections 3 m thick were cut, and slides were prepared. All slides were stained with Giemsa for morphological analysis. The slides from the periods of 10, 30, and 90 days after injection and/or radiation were also stained for reticulin fibers using the Gomori silver method.
Histometry
Histometry was performed in all subgroups at 10, 30, and 90 days (recovery phase) after treatment, in sections stained with the Gomori silver method to assess the number of reticulin fibers. Coded slides were scored blindly. The number of reticulin fibers were counted using an 100-hit integrated lens (Carl Zeiss KF 10×/18) in the light microscope (Olympus BX40F-3). Ten (10) highpowered (×100) fields were randomly selected. Onehundred hits were counted in each field (total of 1,000 hits per slide). Each hit was scored for the presence of cell and reticulin fiber. The number of reticulin fibers (relative to the 1,000 hits) examined was calculated for each animal. The results were submitted to statistical analysis [50, 51] .
Statistical Analysis
The Kruskall-Wallis test [52] was used to compare the results of reticulin fiber counting 10, 30, and 90 days after injection and/or radiation. This test was set separately for each group (Ami , groups the Mann-Whitney test was used. Standard error (SE) was also calculated [52] , and P values Յ0.05 were considered statistically significant.
Antibodies
The following primary antibodies were used: goat polyclonal immunoglobulin IgG antihuman LAP (TGF␤1) (R&D Systems Inc., Minneapolis, MN), rabbit polyclonal IgG anti mouse, rat, and human TGF␤1 (Santa Cruz Biotechnology, Santa Cruz, CA), goat polyclonal IgG anti mouse, rat, and human smad 2/3 (Santa Cruz Biotechnology), rabbit polyclonal IgG anti mouse, rat, and human smad 4 (Santa Cruz Biotechnology), and a goat polyclonal IgG anti mouse, rat, and human smad 7 (Santa Cruz Biotechnology).
Immunohistochemistry
Immunohistochemistry was performed by an indirect three-stage immunoenzymatic procedure. Serial slides of 3 m were mounted on 3-aminopropyltriethoxysilane (Sigma, St. Louis, MO) precoated slides. After deparaffinization, the sections were incubated overnight with the primary antibodies (1:100) at room temperature.
After a wash step with phosphate-buffered saline (PBS), the sections were incubated with the biotinylated secondary antibodies (1:250) for 3 hr. Subsequently, an Extra-avidin conjugated with alkaline phosphatase (Sigma) to detect latent TGF␤1, active TGF␤1, smad 2/3, smad 4, and smad 7 was added for 2 hr. To display alkaline phosphatase activity the slides were incubated with substrate using a mixture of naphthol AS-MX phosphate, levamizole, and a chromogenic salt diluted in veronal acetate buffer (pH 8. 
Immunohistochemical Analysis
TGF␤1. In all non-irradiated bone marrows, at all time periods studied, amifostine-treated (Ami (Table I) In the non-irradiated marrows, whether they were amifostine-treated (Ami (Table I) . Immunopositivity to smad 7 was not detected in the cytoplasm or in the nucleus of the non-irradiated and untreated megakaryocytes (Ami (Table I ). In addition, a strong immunopositivity to smad 7 was detected in the cytoplasm of megakaryocytes in this group (Table I, Fig. 2G ). At the same time, bone marrows showed a better cellularity compared to the untreated ones. These results suggest that TGF␤1 signal transduction is occurring in megakaryocytes in untreated marrows (Ami 
DISCUSSION
The radiation injuries in bone marrow cells were attenuated at all time periods by amifostine, supporting the findings of other studies [7] [8] [9] . It was also shown that the number of reticulin fibers was lower 10 days after irradiation in Ami Amifostine has been found to protect the gastrointestinal tract of mice from late effects of radiation such as ulceration, fibrosis, and vascular changes by a protection factor of 1.3 [10] . In the present study, the significantly lower amount of reticulin fibers seen 10 days after irradiation in Ami These findings are consistent with other reports in the literature, which show the presence of TGF␤1 in megakaryocytes and platelets [35, 36] . However, the expression of active TGF␤1 was not detected in megakaryocytes, in the non-irradiated bone marrows (Ami TGF␤ is a known modulator of hematopoietic cells [53] and megakaryocytes are the major site of synthesis and storage of TGF␤1 [35] . In platelets, TGF␤ was found stored in the latent form [35, 36] . It has been suggested that the fate of TGF␤1 produced by megakaryocytes is packaging into platelet ␣-granules for use primarily in wound healing [35] . The platelet latent complex has also been postulated to be a "delivery" complex, extending the half life of the protein and insuring that TGF␤1 acts in target cells capable of activating the latent form [36] . Considering these aspects we would expect to find a positivity to latent TGF␤1 in megakaryocytes in physiological conditions.
During the bone marrow injury phase, 4, 12, and 24 hr after irradiation, in (Ami [53] . Data also showed activation at the TGF␤ protein level in vivo, although, no significant increase in the levels of TGF␤ mRNA after 7.75 Gy has been demonstrated [45] . The detection of latent TGF␤1 activation in megakaryocytes at 10 days, and persisting until 30 days after irradiation, indicates a delayed activation of TGF␤1 in this cell type. In tissues, such as mammary gland cells, TGF␤ was found activated within hours and also days after irradiation [42, 44] . Early activation was suggested to be the consequence of oxidative stress from the free radicals induced by radiation and the continued elevation, probably due to a cell-mediated mechanism, via plasmin. With reference to our results, we suggest that the delayed radiation-induced activation of latent TGF␤1 detected in megakaryocytes in Ami It is also important to mention that 10 days after irradiation, the initial fibrosis was increased in (Ami − /rad + ) group concomitant with active TGF␤1 positive megakaryocytes. With regard to the cellular sources of active TGF␤1 in the bone marrow, which could stimulate fibrosis, studies of some hematological diseases, such as myelofibrosis, suggest that megakaryocytes are the source [40, 41] . However, others have reported that monocytes may be the source of TGF␤1 [39] . In physiological conditions monocytes, neutrophils, and megakaryocytes were found to produce TGF␤1 [34, 35] . Therefore, the cellular sources possibly involved in the bone marrow fibrosis are not clearly defined and could be multiple. We suggest that the active TGF␤1 positive megakaryocytes present in the foci of hematopoiesis in irradiated bone marrows (Ami . It is possible that under physiological conditions the amount of smad 7 in these cells is too small to be detected immunohistochemically. However, after irradiation, a strong immunopositivity to smad 7 was detected in the nucleus in the (Ami − /rad + ) group. The expression of inhibitory smad 7 protein was found to be localized within the nucleus in the absence of ligand and translocated to the cytoplasm upon TGF␤1 stimulation where it may act in an autoregulatory negative feedback loop [30] . In addition, smad 7 mRNA expression was reported to be induced by TGF␤1 [29] . Our results showed smad 7 immunopositivity in the nucleus of irradiated and untreated Ami − / rad + megakaryocytes concomitant with positive immunoexpression of active TGF␤1. We suggest that activation of latent TGF␤1 in active TGF␤1 by radiation stimulates smad 7 production in megakaryocytes and the protein accumulates within the nucleus. At the time assessed, smad 7 had not been translocated to the cytoplasm and the autoregulatory negative feedback was not functioning in Ami − /rad + megakaryocytes. Therefore, TGF␤1 signal transduction was occurring in these cells. These findings suggest a role for TGF␤1 as an inhibitor of megakaryocytes. Immunopositivity to smad 7 was detected in the cytoplasm of non-irradiated and amifostinetreated megakaryocytes (Ami + /rad − ). These results suggest that amifostine itself activates smad 7, which translocates to the cytoplasm since active TGF␤1 was negative in these cells. After irradiation, smad 7 immunopositivity increased in the cytoplasm of amifostinetreated megakaryocytes (Ami + /rad − ). In this case, amifostine and also active TGF␤1 could have contributed to smad 7 activation. The final result is the inhibition of TGF␤1 signal transduction in megakaryocytes, in irradiated amifostine-treated bone marrows (Ami + /rad + ). To our knowledge, this is the first report showing smad 7 activation by amifostine. Recently, it has been reported that interferon ␥ (IFN-␥), which has been used to treat radiation-induced fibrosis [55, 56] , induces the expression of smad 7 protein in osteosarcoma cells, thus preventing the cellular response to TGF␤1 [57] . Taken together our data suggest that active TGF␤1 has a role in the inhibition of megakaryocytes in vivo. Results also indicate that amifostine does not prevent latent TGF␤1 activation in irradiated megakaryocytes. Whilst TGF␤1 signal transduction occurs in megakaryocytes in untreated bone marrows (Ami − /rad + ), it is inhibited in megakaryocytes in amifostine-treated marrows (Ami + / rad + ) due to the induction of smad 7 activation. It is possible that the inhibition of the TGF␤1 signal transduction cascade, and consequently its inhibitory growth signal could be a mechanism of radioprotection for other bone marrow cells, which contributes to the faster recovery of cellularity induced by amifostine. Our results also suggest that amifostine may be an effective agent for preventing radiation-induced fibrosis in the bone marrow and one possible mechanism for its action could be due to the induction of smad 7 activation.
